CLINICAL_TRIALS
trial_result
· 2024-02-14
Clinical Trial Update: Safety and Efficacy of TOP1630 for Dry Eye Syndrome [Phase 2]
Summary
Phase 2 trial results for TOP1630 in dry eye syndrome have been completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: ORA, Inc. | Conditions: Dry Eye Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2024-02-14